Jeff Karp

Jeff Karp is the Co-Founder of Akita Biosciences, Co-Founder of Corner Therapeutics, Co-Director of Regenerative Therapeutics at Brigham and Women's Hospital, Co-Founder of Landsdowne Labs, Editorial Advisory Board Member at TEDMED, Co-Founder at Alivio Therapeutics, Associate Member at Broad Institute, Co-Founder at Frequency Therapeutics, and Co-Founder and Chairman of the Scientific & Clinical Advisory Boards at TISSIUM. Jeff is also the Author of LIT - Life Ignition Tools published by HarperCollins Publishers. Jeff holds a PostDoc in Stem Cells and Advanced Biomaterials from Massachusetts Institute of Technology, a PhD in Chemical and Biomedical Engineering from University of Toronto, and a BENG in Chemical Engineering from McGill University.